David Brautigan

David Brautigan

Corporate Officer/Principal at University of Virginia

Consumer Services
Finance

Profile

In addition to his role with Tall Oaks, Dr. Brautigan has been Director of the Center for Cell Signaling and a Professor of Microbiology and Medicine with the University of Virginia School of Medicine since 1994.
Prior to his tenure at UVA, he was a Professor of Medical Science at Brown University in Rhode Island for eight years and served as an Associate Professor of Biochemistry at the University of Washington School of Medicine in Seattle, Washington where he was also a Research Fellow in the laboratory of Edmond H.
Fischer, Ph.D.
Dr. Brautigan has served on multiple boards and committees at the University of Virginia and related community Boards to encourage best practices in research and development, technology transfer and entrepreneurship.
Dr. Brautigan has over 160 peer-reviewed publications and manages multiple grants to study the mechanisms of action involved with protein phosphatases.
The results of his studies are expected to help understanding of cell adhesion and migration, smooth muscle contractility, morphogenesis during development and how defects in these processes lead to human diseases.

David Brautigan active positions

CompaniesPositionStart
University of Virginia Corporate Officer/Principal 1993-12-31
All active positions of David Brautigan

Former positions of David Brautigan

CompaniesPositionEnd
Brown University Corporate Officer/Principal 1993-12-30
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of David Brautigan's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Brautigan's experience

Connections

100 +

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies1

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. David Brautigan
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW